This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

EDAP Introduces Focal.One(R): A New Robotic HIFU Device For Focal Therapy Of Prostate Cancer

LYON, France, March 14, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the launch of Focal.One ® , its new and innovative robotic HIFU device fully dedicated to focal therapy of prostate cancer. Focal.One ® will be showcased for the first time at the European Association of Urology (EAU) 28 th Annual Congress to be held in Milan, Italy on March 15-19, 2013 (booth # D41).

Marc Oczachowski, Chief Executive Officer of EDAP TMS, commented, "We are very excited to present to the urological community our latest HIFU technology bringing together many of the latest innovations to fulfill the focal strategy for the treatment of prostate cancer. Focal.One is the first and only device specifically designed to fully answer the need from urologists for a non-invasive, robotic device that fully addresses the quality of life preservation concerns of prostate cancer patients who are increasingly better informed about treatment options."

Focal.One is the first device dedicated to the focal approach for prostate cancer therapy. It combines the three essential components to efficiently perform a focal treatment: (i) state-of-the-art imaging to localize tumors with the use of magnetic resonance imaging (MRI) combined with real-time ultrasound, (ii) utmost precision of HIFU treatment focused on identified targeted cancer areas only and (iii) immediate feedback on treatment efficacy utilizing Contrast-Enhanced Ultrasound Imaging.

As the prostate cancer patient profile has evolved over recent years with earlier diagnosis and life expectancy significantly increasing, men with prostate cancer want to preserve their quality of life more than ever. Until today, those patients are mainly offered two options to address their prostate cancer: either a radical treatment approach with the surgical removal or irradiation of the entire prostatic gland, usually associated with high risk of side effects such as incontinence and impotence, or a "watchful waiting" approach with the monitoring of disease evolution through regular PSA testing and biopsies, usually associated with a high degree patient stress and anxiety ultimately resulting in the necessity for a radical treatment. Between "over-aggressive treatment" and "no treatment," there is definitely a need for a non-invasive therapeutic alternative that offers a control over the disease while focally treating the cancer tumors only.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,630.27 +189.68 1.09%
S&P 500 2,093.25 +25.61 1.24%
NASDAQ 5,089.2060 +49.43 0.98%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs